Addex Therapeutics (ADXN) Equity Ratio (2022 - 2025)
Historic Equity Ratio for Addex Therapeutics (ADXN) over the last 3 years, with Q4 2024 value amounting to 0.91.
- Addex Therapeutics' Equity Ratio rose 26725.12% to 0.91 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.91, marking a year-over-year increase of 26725.12%. This contributed to the annual value of 0.91 for FY2024, which is 26725.12% up from last year.
- Latest data reveals that Addex Therapeutics reported Equity Ratio of 0.91 as of Q4 2024, which was up 26725.12% from 0.25 recorded in Q4 2023.
- Addex Therapeutics' Equity Ratio's 5-year high stood at 0.91 during Q4 2024, with a 5-year trough of 0.25 in Q4 2023.
- In the last 3 years, Addex Therapeutics' Equity Ratio had a median value of 0.59 in 2022 and averaged 0.58.
- In the last 5 years, Addex Therapeutics' Equity Ratio tumbled by 5840.07% in 2023 and then surged by 26725.12% in 2024.
- Addex Therapeutics' Equity Ratio (Quarter) stood at 0.59 in 2022, then tumbled by 58.4% to 0.25 in 2023, then soared by 267.25% to 0.91 in 2024.
- Its Equity Ratio stands at 0.91 for Q4 2024, versus 0.25 for Q4 2023 and 0.59 for Q4 2022.